{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:49:59Z","timestamp":1768441799622,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:00:00Z","timestamp":1339545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1742-2094-9-124","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T14:14:10Z","timestamp":1340633650000},"source":"Crossref","is-referenced-by-count":61,"title":["Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice"],"prefix":"10.1186","volume":"9","author":[{"given":"Qingshan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Joo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan-Khanh Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyung","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoying","family":"Bing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung-Chun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jau-Shyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"583_CR1_583","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","volume":"15","author":"AM Graybiel","year":"2005","unstructured":"Graybiel AM: The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 2005, 15:638\u2013644.","journal-title":"Curr Opin Neurobiol"},{"key":"583_CR2_583","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1523\/JNEUROSCI.6146-08.2009","volume":"29","author":"AN Carey","year":"2009","unstructured":"Carey AN, Lyons AM, Shay CF, Dunton O, McLaughlin JP: Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory. J Neurosci 2009, 29:4293\u20134300.","journal-title":"J Neurosci"},{"key":"583_CR3_583","first-page":"293","volume":"82","author":"MS Reid","year":"1990","unstructured":"Reid MS, Herrera-Marschitz M, Hokfelt T, Lindefors N, Persson H, Ungerstedt U: Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Exp Brain Res 1990, 82:293\u2013303.","journal-title":"Exp Brain Res"},{"key":"583_CR4_583","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002210050545","volume":"123","author":"H Steiner","year":"1998","unstructured":"Steiner H, Gerfen CR: Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 1998, 123:60\u201376.","journal-title":"Exp Brain Res"},{"key":"583_CR5_583","first-page":"1307","volume":"290","author":"ZB You","year":"1999","unstructured":"You ZB, Herrera-Marschitz M, Terenius L: Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J Pharmacol Exp Ther 1999, 290:1307\u20131315.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR6_583","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","volume":"11","author":"CR Gerfen","year":"1991","unstructured":"Gerfen CR, McGinty JF, Young WS: Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 1991, 11:1016\u20131031.","journal-title":"J Neurosci"},{"key":"583_CR7_583","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","volume":"116","author":"TS Shippenberg","year":"2007","unstructured":"Shippenberg TS, Zapata A, Chefer VI: Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 2007, 116:306\u2013321.","journal-title":"Pharmacol Ther"},{"key":"583_CR8_583","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","volume":"25","author":"CM Waters","year":"1988","unstructured":"Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP: Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson\u2019s disease and Huntington\u2019s chorea. Neuroscience 1988, 25:419\u2013438.","journal-title":"Neuroscience"},{"key":"583_CR9_583","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100720170046","volume":"22","author":"A Carta","year":"2001","unstructured":"Carta A, Fenu S, Morelli M: Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson\u2019s disease. Neurol Sci 2001, 22:59\u201360.","journal-title":"Neurol Sci"},{"key":"583_CR10_583","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard E, Brotchie JM, Gross CE: Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001, 2:577\u2013588.","journal-title":"Nat Rev Neurosci"},{"key":"583_CR11_583","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-002-0715-6","volume":"109","author":"R Klintenberg","year":"2002","unstructured":"Klintenberg R, Svenningsson P, Gunne L, Andren PE: Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. J Neural Transm 2002, 109:1295\u20131307.","journal-title":"J Neural Transm"},{"key":"583_CR12_583","first-page":"1133","volume":"298","author":"B Liu","year":"2001","unstructured":"Liu B, Qin L, Yang SN, Wilson BC, Liu Y, Hong JS: Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Ther 2001, 298:1133\u20131141.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR13_583","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1096\/fj.05-4553com","volume":"20","author":"ML Block","year":"2006","unstructured":"Block ML, Li G, Qin L, Wu X, Pei Z, Wang T, Wilson B, Yang J, Hong JS: Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 2006, 20:251\u2013258.","journal-title":"FASEB J"},{"key":"583_CR14_583","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1096\/fj.04-2857com","volume":"19","author":"L Qin","year":"2005","unstructured":"Qin L, Block ML, Liu Y, Bienstock RJ, Pei Z, Zhang W, Wu X, Wilson B, Burka T, Hong JS: Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J 2005, 19:550\u2013557.","journal-title":"FASEB J"},{"key":"583_CR15_583","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0169-328X(00)00264-3","volume":"86","author":"N Sharifi","year":"2001","unstructured":"Sharifi N, Diehl N, Yaswen L, Brennan MB, Hochgeschwender U: Generation of dynorphin knockout mice. Brain Res Mol Brain Res 2001, 86:70\u201375.","journal-title":"Brain Res Mol Brain Res"},{"key":"583_CR16_583","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2009.05.028","volume":"219","author":"XV Nguyen","year":"2009","unstructured":"Nguyen XV, Liu M, Kim HC, Bing G: Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP. Exp Neurol 2009, 219:228\u2013238.","journal-title":"Exp Neurol"},{"key":"583_CR17_583","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2009.05.015","volume":"104","author":"EJ Shin","year":"2009","unstructured":"Shin EJ, Jang CG, Bing G, Park DH, Oh CH, Koo KH, Oh KW, Yamada K, Nabeshima T, Kim HC: Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice. Drug Alcohol Depend 2009, 104:175\u2013184.","journal-title":"Drug Alcohol Depend"},{"key":"583_CR18_583","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RKW, Huston JP: Behavioral phenotypine of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 2001, 125:109\u2013122.","journal-title":"Behav Brain Res"},{"key":"583_CR19_583","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033338","volume":"1","author":"RKW Schwarting","year":"1999","unstructured":"Schwarting RKW, Sedelis M, Hofele K, Auburger GW, Huston JP: Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkonson\u2019s disease. Neurotox Res 1999, 1:41\u201356.","journal-title":"Neurotox Res"},{"key":"583_CR20_583","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2007.10.044","volume":"151","author":"J Chou","year":"2008","unstructured":"Chou J, Luo Y, Kuo CC, Powers K, Shen H, Harvey BK, Hoffer BJ, Wang Y: Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 2008, 151:92\u2013103.","journal-title":"Neuroscience"},{"key":"583_CR21_583","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2009.05.028","volume":"219","author":"XV Nguyen","year":"2009","unstructured":"Nguyen XV, Liu M, Kim HC, Bing G: Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP. Exp Neurol 2009, 219:228\u2013238.","journal-title":"Exp Neurol"},{"key":"583_CR22_583","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","volume":"186","author":"L Qian","year":"2011","unstructured":"Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, Wilson B, Lu RB, Hong JS, Flood PM: beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol 2011, 186:4443\u20134454.","journal-title":"J Immunol"},{"key":"583_CR23_583","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2011.03.022","volume":"59","author":"EJ Shin","year":"2011","unstructured":"Shin EJ, Duong CX, Nguyen TX, Bing G, Bach JH, Park DH, Nakayama K, Ali SF, Kanthasamy AG, Cadet JL, et al.: PKC\u03b4 inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment. Neurochem Int 2011, 59:39\u201350.","journal-title":"Neurochem Int"},{"key":"583_CR24_583","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1096\/fj.06-6006com","volume":"20","author":"W Zhang","year":"2006","unstructured":"Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Zhang W, Hong JS, Kim HC: 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage bothin vivoandin vitro. FASEB J 2006, 20:2496\u20132511.","journal-title":"FASEB J"},{"key":"583_CR25_583","first-page":"89","volume-title":"3rdInternational Drug Abuse Research Society Meeting. Poster 62; 23\u201326 August 2011","author":"TXK Nguyen","year":"2011","unstructured":"Nguyen TXK, Bach JH, Pham DT, Shin EJ, Hong JS, Kim HC: Prodynorphin gene depletion exacerbates dopaminergic neurotoxicity induced by MPTP or methamphetamine. In 3rdInternational Drug Abuse Research Society Meeting. Poster 62; 23\u201326 August 2011. Edited by: Syed F. Ali: International Drug Abuse Research Society, Istanbul, Turkey; 2011:89."},{"key":"583_CR26_583","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0024-3205(02)02505-5","volume":"72","author":"HC Kim","year":"2003","unstructured":"Kim HC, Shin CY, Seo DO, Jhoo JH, Jhoo WK, Kim WK, Shin EJ, Lee YH, Lee PH, Ko KH: New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice. Life Sci 2003, 72:1883\u20131895.","journal-title":"Life Sci"},{"key":"583_CR27_583","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuint.2009.10.005","volume":"56","author":"BD Jung","year":"2010","unstructured":"Jung BD, Shin EJ, Nguyen XK, Jin CH, Bach JH, Park SJ, Nah SY, Wie MB, Bing G, Kim HC: Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochem Int 2010, 56:229\u2013244.","journal-title":"Neurochem Int"},{"key":"583_CR28_583","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(99)02122-8","volume":"851","author":"HC Kim","year":"1999","unstructured":"Kim HC, Jhoo WK, Choi DY, Im DH, Shin EJ, Suh JH, Floyd RA, Bing G: Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res 1999, 851:76\u201386.","journal-title":"Brain Res"},{"key":"583_CR29_583","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435\u201313444.","journal-title":"J Neurosci"},{"key":"583_CR30_583","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)90534-7","volume":"668","author":"G Bing","year":"1994","unstructured":"Bing G, Zhang Y, Watanabe Y, McEwen BS, Stone EA: Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res 1994, 668:261\u2013265.","journal-title":"Brain Res"},{"key":"583_CR31_583","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2967\/jnumed.106.037796","volume":"48","author":"D Pellegrino","year":"2007","unstructured":"Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL: Modulation of dopaminergic and glutamatergic brain function: PET Studies on Parkinsonian rats. J Nucl Med 2007, 48:1147\u20131153.","journal-title":"J Nucl Med"},{"key":"583_CR32_583","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1369\/jhc.5A6758.2005","volume":"54","author":"OA Maximova","year":"2006","unstructured":"Maximova OA, Taffs RE, Pomeroy KL, Piccardo P, Asher DM: Computerized morphometric analysis of pathological prion protein deposition in scrapie-infected hamster brain. J Histochem Cytochem 2006, 54:97\u2013107.","journal-title":"J Histochem Cytochem"},{"key":"583_CR33_583","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ: Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482\u2013497.","journal-title":"Anat Rec"},{"key":"583_CR34_583","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM: TNF-alpha knockout and minocycline treatment attenuates blood\u2013brain barrier leakage in MPTP-treated mice. Neurobiol Dis 2007, 26:36\u201346.","journal-title":"Neurobiol Dis"},{"key":"583_CR35_583","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen HJ, Jensen EB, Kieu K, Nielsen J: The efficiency of systematic sampling in stereology\u2013reconsidered. J Microsc 1999, 193:199\u2013211.","journal-title":"J Microsc"},{"key":"583_CR36_583","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroscience.2004.08.050","volume":"130","author":"C Schmitz","year":"2005","unstructured":"Schmitz C, Hof PR: Design-based stereology in neuroscience. Neuroscience 2005, 130:813\u2013831.","journal-title":"Neuroscience"},{"key":"583_CR37_583","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","volume":"30","author":"C Malagelada","year":"2010","unstructured":"Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA: Rapamycin protects against neuron death inin vitroandin vivomodels of Parkinson\u2019s disease. J Neurosci 2010, 30:1166\u20131175.","journal-title":"J Neurosci"},{"key":"583_CR38_583","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","volume":"98","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S: Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 2001, 98:2837\u20132842.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"583_CR39_583","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neuron.2007.12.019","volume":"57","author":"D Belin","year":"2008","unstructured":"Belin D, Everitt BJ: Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008, 57:432\u2013441.","journal-title":"Neuron"},{"key":"583_CR40_583","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","volume":"55","author":"T Karl","year":"2003","unstructured":"Karl T, Pabst R, von Horsten S: Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 2003, 55:69\u201383.","journal-title":"Exp Toxicol Pathol"},{"key":"583_CR41_583","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-8993(96)01162-6","volume":"49","author":"G Rozas","year":"1997","unstructured":"Rozas G, Labandeira Garcia JL: Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res 1997, 49:188\u2013199.","journal-title":"Brain Res"},{"key":"583_CR42_583","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"583_CR43_583","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","volume":"17","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS: Critical role of microglial NADPH oxidase-derived free radicals in thein vitroMPTP model of Parkinson's disease. FASEB J 2003, 17:1954\u20131956.","journal-title":"FASEB J"},{"key":"583_CR44_583","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awp333","volume":"133","author":"S Levesque","year":"2010","unstructured":"Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML: Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 2010, 133:808\u2013821.","journal-title":"Brain"},{"key":"583_CR45_583","doi-asserted-by":"crossref","first-page":"E847","DOI":"10.1208\/aapsj070481","volume":"7","author":"EL Riddle","year":"2005","unstructured":"Riddle EL, Fleckenstein AE, Hanson GR: Role of monoamine transporters in mediating psychostimulant effects. AAPS J 2005, 7:E847\u2013851.","journal-title":"AAPS J"},{"key":"583_CR46_583","first-page":"834","volume":"282","author":"AE Fleckenstein","year":"1997","unstructured":"Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR: Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 1997, 282:834\u2013838.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR47_583","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2007.09.028","volume":"1185","author":"S Vergo","year":"2007","unstructured":"Vergo S, Johansen JL, Leist M, Lotharius J: Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels. Brain Res 2007, 1185:18\u201332.","journal-title":"Brain Res"},{"key":"583_CR48_583","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-8993(00)02085-0","volume":"862","author":"HC Kim","year":"2000","unstructured":"Kim HC, Jhoo WK, Shin EJ, Bing G: Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model. Brain Research 2000, 862:247\u2013252.","journal-title":"Brain Research"},{"key":"583_CR49_583","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(96)00995-X","volume":"738","author":"PK Sonsalla","year":"1996","unstructured":"Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED: Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Research 1996, 738:172\u2013175.","journal-title":"Brain Research"},{"key":"583_CR50_583","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(96)00968-7","volume":"742","author":"ED Hall","year":"1996","unstructured":"Hall ED, Andrus PK, Oostveen JA, Althaus JS, VonVoigtlander PF: Neuroprotective effects of the dopamine D2\/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Research 1996, 742:80\u201388.","journal-title":"Brain Research"},{"key":"583_CR51_583","first-page":"889","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S: Parkinson\u2019s disease: mechanisms and models. Neuron. 2003, 39:889\u2013909.","journal-title":"Parkinson\u2019s disease: mechanisms and models. Neuron"},{"key":"583_CR52_583","first-page":"1571","volume":"268","author":"JF Bowyer","year":"1994","unstructured":"Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR: Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994, 268:1571\u20131580.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR53_583","first-page":"1104","volume":"275","author":"DS Albers","year":"1995","unstructured":"Albers DS, Sonsalla PK: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 1995, 275:1104\u20131114.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR54_583","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0028-3908(83)90075-8","volume":"22","author":"GA Ricaurte","year":"1983","unstructured":"Ricaurte GA, Fuller RW, Perry KW, Seiden LS, Schuster CR: Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of D-methamphetamine and D-amphetamine. Neuropharmacology 1983, 22:1165\u20131169.","journal-title":"Neuropharmacology"},{"key":"583_CR55_583","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(83)90602-9","volume":"270","author":"GC Wagner","year":"1983","unstructured":"Wagner GC, Lucot JB, Schuster CR, Seiden LS: \u03b1-Methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Research 1983, 270:285\u2013288.","journal-title":"Brain Research"},{"key":"583_CR56_583","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1523\/JNEUROSCI.19-07-02424.1999","volume":"19","author":"F Fumagalli","year":"1999","unstructured":"Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG: Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 1999, 19:2424\u20132431.","journal-title":"J Neurosci"},{"key":"583_CR57_583","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1471-4159.2002.01210.x","volume":"83","author":"L Qin","year":"2002","unstructured":"Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS: Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 2002, 83:973\u2013983.","journal-title":"J Neurochem"},{"key":"583_CR58_583","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","volume":"31","author":"HM Gao","year":"2011","unstructured":"Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS: HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 2011, 31:1081\u20131092.","journal-title":"J Neurosci"},{"key":"583_CR59_583","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/glia.20532","volume":"55","author":"W Zhang","year":"2007","unstructured":"Zhang W, Dallas S, Zhang D, Guo JP, Pang H, Wilson B, Miller DS, Chen B, McGeer PL, Hong JS, Zhang J: Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia 2007, 55:1178\u20131188.","journal-title":"Glia"},{"key":"583_CR60_583","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.4049\/jimmunol.181.10.7194","volume":"181","author":"X Hu","year":"2008","unstructured":"Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA, Ali SF, Zhang J, Block ML, Hong JS: Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol 2008, 181:7194\u20137204.","journal-title":"J Immunol"},{"key":"583_CR61_583","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2004.01.010","volume":"187","author":"MJ LaVoie","year":"2004","unstructured":"LaVoie MJ, Card JP, Hastings TG: Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol 2004, 187:47\u201357.","journal-title":"Exp Neurol"},{"key":"583_CR62_583","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D: Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 2003, 54:599\u2013604.","journal-title":"Ann Neurol"},{"key":"583_CR63_583","first-page":"61","volume":"280","author":"LY Kong","year":"1997","unstructured":"Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS: Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 1997, 280:61\u201366.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-2094-9-124\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T07:57:19Z","timestamp":1561881439000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-9-124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-9-124","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]},"article-number":"583"}}